Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 6090 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 6281 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 7881 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 7966 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 8176 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 8945 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 9362 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | 20855 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | TRANS-4-HYDROXYPROLINE (CAS# 51-35-4); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |